Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • ID: 4384382
  • Report
  • 205 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • A&G Pharmaceutical Inc
  • Abcodia Ltd
  • Acobiom
  • Andraka Technologies, LLC
  • Applied Proteomics Inc
  • Avant Diagnostics, Inc.
  • MORE
Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

The author's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Pancreatic Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pancreatic Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Pancreatic Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Pancreatic Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Pancreatic Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • A&G Pharmaceutical Inc
  • Abcodia Ltd
  • Acobiom
  • Andraka Technologies, LLC
  • Applied Proteomics Inc
  • Avant Diagnostics, Inc.
  • MORE
1 Table of Contents
2 Introduction
2.1 Pancreatic Cancer Diagnostic Tests Overview
3 Products under Development
3.1 Pancreatic Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Pancreatic Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Pancreatic Cancer - Pipeline Products by Regulatory Path
3.4 Pancreatic Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Pancreatic Cancer Diagnostic Tests - Ongoing Clinical Trials
4 Pancreatic Cancer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Pancreatic Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Pancreatic Cancer Diagnostic Tests - Pipeline Products by Stage of Development
5 Pancreatic Cancer Diagnostic Tests Companies and Product Overview
5.1 A&G Pharmaceutical Inc Company Overview
5.1.1 A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Abcodia Ltd Company Overview
5.2.1 Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Acobiom Company Overview
5.3.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview
5.4 Advanced Marker Discovery SL Company Overview
5.4.1 Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
5.5 Andraka Technologies, LLC Company Overview
5.5.1 Andraka Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 Applied Proteomics Inc Company Overview
5.6.1 Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Avant Diagnostics, Inc. Company Overview
5.7.1 Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 BioMarker Strategies LLC Company Overview
5.8.1 BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Bioprognos SL Company Overview
5.9.1 Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
5.10 Biouniversa srl Company Overview
5.10.1 Biouniversa srl Pipeline Products & Ongoing Clinical Trials Overview
5.11 Cancer Research Technology Ltd Company Overview
5.11.1 Cancer Research Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.12 Cepheid Company Overview
5.12.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview
5.13 Clovis Oncology Inc Company Overview
5.13.1 Clovis Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 CompanDX Ltd. Company Overview
5.14.1 CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.15 Courtagen Life Sciences Inc Company Overview
5.15.1 Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 CS-Keys, Inc. (Inactive) Company Overview
5.16.1 CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.17 Di.V.A.L Toscana srl Company Overview
5.17.1 Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview
5.18 Exact Sciences Corp Company Overview
5.18.1 Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.19 Fred Hutchinson Cancer Research Center Company Overview
5.19.1 Fred Hutchinson Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
5.20 German Cancer Research Center Company Overview
5.20.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
5.21 GlycoZym Company Overview
5.21.1 GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
5.22 Health Discovery Corp Company Overview
5.22.1 Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview
5.23 Hebrew University of Jerusalem Company Overview
5.23.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
5.24 ImmunoCellular Therapeutics Ltd Company Overview
5.24.1 ImmunoCellular Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 Immunomedics Inc Company Overview
5.25.1 Immunomedics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Immunovia AB Company Overview
5.26.1 Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview
5.27 Imperial College London Company Overview
5.27.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.28 IV Diagnostics, Inc. Company Overview
5.28.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.29 John Hopkins University Company Overview
5.29.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.30 Leitat Technological Center Company Overview
5.30.1 Leitat Technological Center Pipeline Products & Ongoing Clinical Trials Overview
5.31 Luminor Medical Technologies Inc Company Overview
5.31.1 Luminor Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Matrix-Bio, Inc. Company Overview
5.32.1 Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.33 Mayo Clinic US Company Overview
5.33.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
5.34 MDNA Life Sciences Inc Company Overview
5.34.1 MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Merrimack Pharmaceuticals Inc Company Overview
5.35.1 Merrimack Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.36 Metanomics Health GmbH Company Overview
5.36.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.37 Milagen Inc Company Overview
5.37.1 Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
5.38 Myriad Genetics Inc Company Overview
5.38.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.39 Nanocytomics LLC Company Overview
5.39.1 Nanocytomics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.40 NanoScale Corporation Company Overview
5.40.1 NanoScale Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.41 NatiMab Therapeutics Srl Company Overview
5.41.1 NatiMab Therapeutics Srl Pipeline Products & Ongoing Clinical Trials Overview
5.42 National Cheng-Kung University Hospital Company Overview
5.42.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.43 Oncomatryx Biopharma SL Company Overview
5.43.1 Oncomatryx Biopharma SL Pipeline Products & Ongoing Clinical Trials Overview
5.44 Onconome, Inc. (Inactive) Company Overview
5.44.1 Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.45 OPKO Health Inc Company Overview
5.45.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.46 Oxford Gene Technology Ltd Company Overview
5.46.1 Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.47 PeriRx LLC Company Overview
5.47.1 PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview
5.48 Precision Biologics Inc Company Overview
5.48.1 Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.49 Proplex Technologies Llc Company Overview
5.49.1 Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
5.50 Protagen AG Company Overview
5.50.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
5.51 Proteome Sciences Plc Company Overview
5.51.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
5.52 Queen Mary University of London Company Overview
5.52.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
5.53 Rutgers The State University of New Jersey Company Overview
5.53.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview
5.54 SDIX LLC Company Overview
5.54.1 SDIX LLC Pipeline Products & Ongoing Clinical Trials Overview
5.55 Sienna Cancer Diagnostics Ltd Company Overview
5.55.1 Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.56 SomaLogic Inc Company Overview
5.56.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.57 Stanford University Company Overview
5.57.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.58 Temple University Health System Company Overview
5.58.1 Temple University Health System Pipeline Products & Ongoing Clinical Trials Overview
5.59 The Royal Marsden NHS Foundation Trust Company Overview
5.59.1 The Royal Marsden NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
5.60 The University of North Carolina at Chapel Hill Company Overview
5.60.1 The University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview
5.61 Thomas Jefferson University Company Overview
5.61.1 Thomas Jefferson University Pipeline Products & Ongoing Clinical Trials Overview
5.62 University of Illinois at Chicago Company Overview
5.62.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.63 University of Pennsylvania Company Overview
5.63.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview
5.64 University of Texas MD Anderson Cancer Center Company Overview
5.64.1 University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
5.65 US Biomarkers Inc Company Overview
5.65.1 US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
5.66 Ventana Medical Systems Inc Company Overview
5.66.1 Ventana Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.67 Viomics Inc. Company Overview
5.67.1 Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.68 Vitatex Inc. Company Overview
5.68.1 Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.69 VolitionRX Ltd Company Overview
5.69.1 VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Pancreatic Cancer Diagnostic Tests - Recent Developments
6.1 Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories
6.2 Aug 16, 2017: Immunomedics Announces Fiscal 2017 Results and Strategic Developments; Reiterates Guidance on BLA Submission Timeline
6.3 Aug 14, 2017: Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer
6.4 Aug 14, 2017: ImmunoCellular Therapeutics Announces Second Quarter 2017 Financial Results
6.5 Aug 09, 2017: Merrimack Reports Second Quarter 2017 Financial Results
6.6 Aug 08, 2017: Halozyme Reports Second Quarter 2017 Results
6.7 Aug 02, 2017: Clovis Oncology Announces Second Quarter 2017 Operating Results
6.8 Aug 01, 2017: Proteome Sciences: Directorate changes
6.9 Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017
6.10 Jul 25, 2017: NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017
6.11 Jul 25, 2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests
6.12 Jul 17, 2017: Leading expert on pancreatic cancer, Professor Stephen Pereira at University College London, joins Immunovia’s Scientific Advisory Board
6.13 Jul 17, 2017: Leading pancreatic cancer expert on early symptoms Professor Stephen Pereira at University College London joins Immunovia’s Scientific Advisory Board
6.14 Jun 28, 2017: Immunovia Establishes US Headquarters, Including CLIA Reference Laboratory, in Boston
6.15 Jun 27, 2017: Avant Diagnostics Announces Confirmatory Clinical Utility Data for Theralink in Pancreatic Cancer
6.16 Jun 13, 2017: Immunovia's biomarker signature for the diagnosis of pancreatic cancer now patented in Japan
6.17 Jun 13, 2017: Immunovia´s biomarker signature for the diagnosis of pancreatic cancer now patented in Japan
6.18 Jun 13, 2017: Cambridge Biomedical Names Linda Robbie, Ph.D., as VP of Scientific Affairs
6.19 Jun 12, 2017: Proteome Sciences: New Registered Address
6.20 Jun 08, 2017: Merrimack Announces Expansion of Senior Management Team with Appointment of Sergio Santillana as Chief Medical Officer and Ellen Forest as Head of Human Resources
6.21 Jun 01, 2017: Helomics and the Pittsburgh Life Sciences Greenhouse Partner to Establish a Biotechnology Incubator Dedicated to Diagnostics and Precision Medicine
6.22 May 25, 2017: Merrimack Announces Management Change
6.23 May 15, 2017: ImmunoCellular Therapeutics Announces First Quarter 2017 Financial Results
6.24 May 15, 2017: Interpace Diagnostics Group Reports First Quarter 2017 Financial Results, Business Progress and Recent Accomplishments
6.25 May 11, 2017: VolitionRx Announces First Quarter 2017 Financial Results and Business Update
6.26 May 10, 2017: Merrimack Reports First Quarter 2017 Financial Results
6.27 May 10, 2017: Immunomedics Announces Third Quarter Fiscal 2017 Results And Clinical Program Developments
6.28 May 09, 2017: OPKO Health Reports 2016 Financial and Operating Results
6.29 May 09, 2017: Halozyme Reports First Quarter 2017 Financial Results
6.30 May 05, 2017: Immunomedics Delivers Business Updates, Announces Private Placement Offering and Outlines Strategic Steps to Drive Stockholder Value
6.31 May 03, 2017: Clovis Oncology Announces First Quarter 2017 Operating Results
6.32 May 02, 2017: Myriad Genetics Reports Fiscal Third-Quarter 2017 Financial Results
6.33 Apr 26, 2017: NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017
6.34 Apr 20, 2017: Immunovia Interim report, January-March 2017
6.35 Apr 20, 2017: NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development
6.36 Apr 19, 2017: New CEO Appointed From Within Sienna
6.37 Apr 11, 2017: VolitionRx Appoints David Vanston as Chief Financial Officer
6.38 Apr 05, 2017: SomaLogic announces the appointment of long-time Board member as Chief Executive Officer
6.39 Apr 03, 2017: Proteome Sciences Announces Appointment of Richard Dennis as Chief Commercial Officer
6.40 Mar 31, 2017: Edison Issues Update on Immunovia (IMMUNOV)
6.41 Mar 29, 2017: Interpace Diagnostics Group Reports Fourth Quarter and Full Year 2016 Financial Results, Business Progress Against Plan and Recent Accomplishments
6.42 Mar 28, 2017: Proteome Sciences Announces Preliminary results for the year ended 31 December 2016 Notice of AGM
6.43 Mar 10, 2017: VolitionRx Announces Full Fiscal Year 2016 Financial Results and Business Update
6.44 Mar 09, 2017: ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
6.45 Mar 06, 2017: Fluciclovine PET/CT improves radiotherapy targeting for recurrent prostate cancer
6.46 Mar 03, 2017: OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development
6.47 Mar 01, 2017: OPKO Health Reports 2016 Financial and Operating Results
6.48 Mar 01, 2017: Merrimack Reports Fourth Quarter and Full-Year 2016 Financial Results
6.49 Feb 28, 2017: Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results
6.50 Feb 22, 2017: Clovis Oncology Announces 2016 Operating Results
6.51 Feb 22, 2017: NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
6.52 Feb 15, 2017: Immunovia Financial Statement 2016
6.53 Feb 09, 2017: Immunomedics Announces Second Quarter Fiscal 2017 Results and Clinical Program Developments
6.54 Feb 07, 2017: Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results
6.55 Jan 18, 2017: Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO
6.56 Jan 16, 2017: Cancer Research Technology And Varleigh Dx (UK) Launch Test To Support Diagnosis Of Pancreatic Cancer
6.57 Jan 16, 2017: University of Michigan Pancreatic Cancer Center new partner in Immunovia’s global PANFAM-1 prospective validation study
6.58 Jan 09, 2017: Immunomedics Announces Reconstituted Board of Directors and Leadership Succession Plan
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Pancreatic Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Pancreatic Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Pancreatic Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Pancreatic Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Pancreatic Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Pancreatic Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 7: Pancreatic Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Companion Diagnostic Test - Pancreatic Cancer - Product Status
Table 10: Companion Diagnostic Test - Pancreatic Cancer - Product Description
Table 11: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Diagnostic Assay - Pancreatic Cancer - Product Status
Table 13: Diagnostic Assay - Pancreatic Cancer - Product Description
Table 14: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Companion Diagnostic Assay - Masitinib - Product Status
Table 16: Companion Diagnostic Assay - Masitinib - Product Description
Table 17: Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Status
Table 18: Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Description
Table 19: GemciTest - Product Status
Table 20: GemciTest - Product Description
Table 21: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
Table 22: PancreaDix - Product Status
Table 23: PancreaDix - Product Description
Table 24: Andraka Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Diagnostic Test - Pancreatic Cancer - Product Status
Table 26: Diagnostic Test - Pancreatic Cancer - Product Description
Table 27: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: API Diagnostic Test - Pancreatic Cancer - Product Status
Table 29: API Diagnostic Test - Pancreatic Cancer - Product Description
Table 30: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 31: TheraLink Assay - Pancreatic Cancer - Product Status
Table 32: TheraLink Assay - Pancreatic Cancer - Product Description
Table 33: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Ex Vivo Biomarker Test - Pancreatic Cancer - Product Status
Table 35: Ex Vivo Biomarker Test - Pancreatic Cancer - Product Description
Table 36: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
Table 37: MBDAA Pancreatic Cancer Test - Product Status
Table 38: MBDAA Pancreatic Cancer Test - Product Description
Table 39: Biouniversa srl Pipeline Products & Ongoing Clinical Trials Overview
Table 40: BAG3 ELISA Kit - Pancreatic Adenocarcinoma - Product Status
Table 41: BAG3 ELISA Kit - Pancreatic Adenocarcinoma - Product Description
Table 42: BAG3 ELISA Kit - Pancreatic Adenocarcinoma Early Diagnosis - Product Status
Table 43: BAG3 ELISA Kit - Pancreatic Adenocarcinoma Early Diagnosis - Product Description
Table 44: Cancer Research Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 45: IHC Based Test - Pancreatic Cancer - Product Status
Table 46: IHC Based Test - Pancreatic Cancer - Product Description
Table 47: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 48: XPERT Pancreatic CA Early Detection Test - Product Status
Table 49: XPERT Pancreatic CA Early Detection Test - Product Description
Table 50: Xpert Pancreatic CA Monitor Assay - Product Status
Table 51: Xpert Pancreatic CA Monitor Assay - Product Description
Table 52: Clovis Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: hENT1 Companion Diagnostic Test - Product Status
Table 54: hENT1 Companion Diagnostic Test - Product Description
Table 55: CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Biomarker Assay - Pancreatic Cancer - Product Status
Table 57: Biomarker Assay - Pancreatic Cancer - Product Description
Table 58: Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Pancreatic Cancer Diagnostic Panel - Product Status
Table 60: Pancreatic Cancer Diagnostic Panel - Product Description
Table 61: CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 62: caPCNA - Pancreatic Cancer - Product Status
Table 63: caPCNA - Pancreatic Cancer - Product Description
Table 64: Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview
Table 65: NanoMabKv - Pancreatic Cancer - Product Status
Table 66: NanoMabKv - Pancreatic Cancer - Product Description
Table 67: Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Diagnostic Assay - Pancreatic Cancer - Product Status
Table 69: Diagnostic Assay - Pancreatic Cancer - Product Description
Table 70: Fred Hutchinson Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Diagnostic Test - Pancreatic Cancer - Product Status
Table 72: Diagnostic Test - Pancreatic Cancer - Product Description
Table 73: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Diagnostic Assay - Pancreatic Cancer - Product Status
Table 75: Diagnostic Assay - Pancreatic Cancer - Product Description
Table 76: GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Diagnostic Assay - Pancreatic Cancer - Product Status
Table 78: Diagnostic Assay - Pancreatic Cancer - Product Description
Table 79: Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Diagnostic Test - Pancreatic Cancer - Product Status
Table 81: Diagnostic Test - Pancreatic Cancer - Product Description
Table 82: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Diagnostic Assay - Pancreatic Cancer - Product Status
Table 84: Diagnostic Assay - Pancreatic Cancer - Product Description
Table 85: ImmunoCellular Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Diagnostic Test - Pancreatic Cancer - Product Status
Table 87: Diagnostic Test - Pancreatic Cancer - Product Description
Table 88: Immunomedics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Companion Diagnostic Assay - Clivatuzumab - Product Status
Table 90: Companion Diagnostic Assay - Clivatuzumab - Product Description
Table 91: Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview
Table 92: IMMray PanCan-d - Product Status
Table 93: IMMray PanCan-d - Product Description
Table 94: IMMray PanCan-m Test - Product Status
Table 95: IMMray PanCan-m Test - Product Description
Table 96: Immunovia AB - Ongoing Clinical Trials Overview
Table 97: IMMray PanCan-d - Validation of Early Detection Blood Test for Pancreatic Cancer
Table 98: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 99: Prognostic Assay - Pancreatic Cancer - Product Status
Table 100: Prognostic Assay - Pancreatic Cancer - Product Description
Table 101: IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Diagnostic Test - Pancreatic Cancer - Product Status
Table 103: Diagnostic Test - Pancreatic Cancer - Product Description
Table 104: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 105: Protein Biomarker Assay - Pancreatic Cancer - Product Status
Table 106: Protein Biomarker Assay - Pancreatic Cancer - Product Description
Table 107: Leitat Technological Center Pipeline Products & Ongoing Clinical Trials Overview
Table 108: ELISA Kit - S100A4 - Pancreatic Cancer - Product Status
Table 109: ELISA Kit - S100A4 - Pancreatic Cancer - Product Description
Table 110: ELISA Kit - S100P - Pancreatic Cancer - Product Status
Table 111: ELISA Kit - S100P - Pancreatic Cancer - Product Description
Table 112: Luminor Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 113: Diagnostic Test - Pancreatic Cancer - Product Status
Table 114: Diagnostic Test - Pancreatic Cancer - Product Description
Table 115: Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 116: VeraMarker Pancreatic Cancer Test - Product Status
Table 117: VeraMarker Pancreatic Cancer Test - Product Description
Table 118: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
Table 119: Methylation Biomarker Test - Pancreatic Cancer - Product Status
Table 120: Methylation Biomarker Test - Pancreatic Cancer - Product Description
Table 121: MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 122: Diagnostic Assay - Pancreatic Cancer - Product Status
Table 123: Diagnostic Assay - Pancreatic Cancer - Product Description
Table 124: Merrimack Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 125: MM-141 Companion Diagnostic Assay - Pancreatic Cancer - Product Status
Table 126: MM-141 Companion Diagnostic Assay - Pancreatic Cancer - Product Description
Table 127: Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 128: Diagnostic Assay - Pancreatic Cancer - Product Status
Table 129: Diagnostic Assay - Pancreatic Cancer - Product Description
Table 130: Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 131: Immunoassay - Pancreatic Cancer - Product Status
Table 132: Immunoassay - Pancreatic Cancer - Product Description
Table 133: Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 134: myPath Pancreatic Cancer - Product Status
Table 135: myPath Pancreatic Cancer - Product Description
Table 136: Nanocytomics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 137: Screening Test - Pancreatic Cancer - Product Status
Table 138: Screening Test - Pancreatic Cancer - Product Description
Table 139: NanoScale Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 140: Diagnostic Test - Pancreatic Cancer - Product Status
Table 141: Diagnostic Test - Pancreatic Cancer - Product Description
Table 142: NatiMab Therapeutics Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 143: Diagnostic Test - Pancreas Adenocarcinoma - Product Status
Table 144: Diagnostic Test - Pancreas Adenocarcinoma - Product Description
Table 145: National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 146: Diagnostic Biomarker - Pancreatic Cancer - Product Status
Table 147: Diagnostic Biomarker - Pancreatic Cancer - Product Description
Table 148: Oncomatryx Biopharma SL Pipeline Products & Ongoing Clinical Trials Overview
Table 149: ELISA-Based Companion Diagnostic Kit - MTX3 - Product Status
Table 150: ELISA-Based Companion Diagnostic Kit - MTX3 - Product Description
Table 151: Immunohistochemistry Based Companion Diagnostic Kit - MTX3 - Product Status
Table 152: Immunohistochemistry Based Companion Diagnostic Kit - MTX3 - Product Description
Table 153: Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 154: Pan Cancer Screening and Detection Test - Product Status
Table 155: Pan Cancer Screening and Detection Test - Product Description
Table 156: Pan-Cancer Metastatic Marker Test - Product Status
Table 157: Pan-Cancer Metastatic Marker Test - Product Description
Table 158: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 159: Diagnostic Test - Pancreatic Cancer - Product Status
Table 160: Diagnostic Test - Pancreatic Cancer - Product Description
Table 161: Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 162: Diagnostic Test - Pancreatic Cancer - Product Status
Table 163: Diagnostic Test - Pancreatic Cancer - Product Description
Table 164: PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 165: Saliva Test - Pancreatic Cancer - Product Status
Table 166: Saliva Test - Pancreatic Cancer - Product Description
Table 167: Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 168: Diagnostic Assay - Pancreatic Cancer - Product Status
Table 169: Diagnostic Assay - Pancreatic Cancer - Product Description
Table 170: NEO-301 IHC Test - Product Status
Table 171: NEO-301 IHC Test - Product Description
Table 172: Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
Table 173: Biomarker Diagnostic Test - Pancreatic Cancer - Product Status
Table 174: Biomarker Diagnostic Test - Pancreatic Cancer - Product Description
Table 175: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
Table 176: Diagnostic Assay - Pancreatic Cancer - Product Status
Table 177: Diagnostic Assay - Pancreatic Cancer - Product Description
Table 178: Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 179: SysQuant Global Phosphorylation Assay - Biopsy Tissue - Product Status
Table 180: SysQuant Global Phosphorylation Assay - Biopsy Tissue - Product Description
Table 181: Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
Table 182: Biomarker Assay - Pancreatic Ductal Adenocarcinoma - Product Status
Table 183: Biomarker Assay - Pancreatic Ductal Adenocarcinoma - Product Description
Table 184: Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview
Table 185: Blood Test - Pancreatic Cancer - Product Status
Table 186: Blood Test - Pancreatic Cancer - Product Description
Table 187: SDIX LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 188: Pancreatic Cancer Assay - Product Status
Table 189: Pancreatic Cancer Assay - Product Description
Table 190: Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 191: Sienna Test - Pancreatic Cancer - Product Status
Table 192: Sienna Test - Pancreatic Cancer - Product Description
Table 193: SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 194: SOMAscan Assay - Pancreatic Cancer - Product Status
Table 195: SOMAscan Assay - Pancreatic Cancer - Product Description
Table 196: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
Table 197: Biomarker Assay - Pancreatic Cyst - Product Status
Table 198: Biomarker Assay - Pancreatic Cyst - Product Description
Table 199: Temple University Health System Pipeline Products & Ongoing Clinical Trials Overview
Table 200: Diagnostic Test - Pancreatic Cancer - Product Status
Table 201: Diagnostic Test - Pancreatic Cancer - Product Description
Table 202: The Royal Marsden NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
Table 203: Pancreatic Cancer Blood Test - Product Status
Table 204: Pancreatic Cancer Blood Test - Product Description
Table 205: The University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview
Table 206: Biomarker Assay - Pancreatic Cancer - Product Status
Table 207: Biomarker Assay - Pancreatic Cancer - Product Description
Table 208: Thomas Jefferson University Pipeline Products & Ongoing Clinical Trials Overview
Table 209: Diagnostic Test - Pancreatic Cancer - Product Status
Table 210: Diagnostic Test - Pancreatic Cancer - Product Description
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • A&G Pharmaceutical Inc
  • Abcodia Ltd
  • Acobiom
  • Advanced Marker Discovery SL
  • Andraka Technologies, LLC
  • Applied Proteomics Inc
  • Avant Diagnostics, Inc.
  • BioMarker Strategies LLC
  • Bioprognos SL
  • Biouniversa srl
  • Cancer Research Technol
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll